HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Churg-Strauss syndrome versus chronic eosinophilic pneumonia on high-resolution computed tomographic findings.

AbstractOBJECTIVES:
The aim of this study was to compare the high-resolution computed tomographic findings between Churg-Strauss syndrome (CSS) and chronic eosinophilic pneumonia (CEP).
METHODS:
We retrospectively reviewed the clinical records of 16 patients with CSS and 34 patients with CEP.
RESULTS:
Twelve (35%) of the 34 patients with CEP had a history of asthma. Although the subpleural distribution of ground-glass opacities (GGOs) and consolidation was common both in CSS and CEP, the midzone distribution was more frequent in CSS (44%) than in CEP (12%). Centrilobular nodules within GGOs were significantly more frequent in CSS (56%) than in CEP (18%). In contrast, traction bronchiectasis associated with volume loss was demonstrated more frequently in CEP (74%) than in CSS (25%).
CONCLUSIONS:
On high-resolution computed tomography, the presence of the midzone distribution and nodules within GGOs without traction bronchiectasis suggests CSS rather than CEP.
AuthorsMasashi Furuiye, Nobuyuki Yoshimura, Akiko Kobayashi, Meiyo Tamaoka, Yasunari Miyazaki, Yoshio Ohtani, Shuji Miyake, Naohiko Inase, Yasuyuki Yoshizawa
JournalJournal of computer assisted tomography (J Comput Assist Tomogr) Vol. 34 Issue 1 Pg. 19-22 (Jan 2010) ISSN: 1532-3145 [Electronic] United States
PMID20118716 (Publication Type: Comparative Study, Journal Article)
Topics
  • Chronic Disease
  • Churg-Strauss Syndrome (diagnostic imaging)
  • Diagnosis, Differential
  • Female
  • Humans
  • Lung (diagnostic imaging)
  • Male
  • Middle Aged
  • Pulmonary Eosinophilia (diagnostic imaging)
  • Retrospective Studies
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: